CSL Behring’s dedication of its R&D activities to develop novel therapies for sickle ... comprising cell–cell interactions and increased endothelial adhesiveness, endothelial dysfunction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback